Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 Survival free from all-cause mortality in the three cohorts in the Studies Of Left Ventricular Dysfunction (SOLVD) Treatment trial. The patients with ischemic cardiomyopathy and diabetes (n = 534; dashed line) had increased mortality compared with the patients with ischemic cardiomyopathy without diabetes (n = 1,392; solid line) and patients with nonischemic cardiomyopathy (n = 642; dotted line) (p < 0.0001 log-rank for both comparisons.) There was no significant difference in survival between the patients with ischemic cardiomyopathy without diabetes and the patients with nonischemic cardiomyopathy.
|
